NBC news correspondent diagnosed with cancer

Written by Community Health Network on 2/12/2014 7:30:00 AM

In the wake of 2014 Olympic coverage, Tom Brokaw announced that he has multiple myeloma.

The NBC News Special Correspondent released a personal statement stating that he has been diagnosed with cancer of the blood, but that his physicians are very encouraged with the progress he is making.

Multiple myeloma is a cancer that affects plasma cells in bone marrow. When plasma cells become cancerous and grow, they can produce a tumor called a plasmacytoma. These tumors usually develop in the bone. When there is more than one plasma cell tumor, it is called multiple myeloma. 

There are different stages to multiple myeloma, and once it is staged treatment can occur. Treatments can include chemotherapy, radiation, surgery, bisphosphonates and/or plasmapheresis. 

Throughout his treatment (that started last August), Brokaw has continued to work on NBC News projects, including contributing to NBC Sports coverage of the Winter Olympics in Sochi.

“With the exceptional support of my family, medical team and friends, I am very optimistic about the future and look forward to continuing my life, my work and adventures still to come," said Brokaw.

Blood cancer basics
Sumeet Bhatia, M.D., a board certified medical oncologist, hematologist and internal medicine specialist at Community Regional Cancer Center, explains the basics of blood cancer.

For more information on the prevention, diagnosis and treatment of blood cancer, visit eCommunity.com/cancercare.

Source: www.nbcnews.com

Appointments available!

To make an appointment with an MD Anderson Cancer Network® certified physician at Community, call 800-777-7775 today!

Community first healthcare organization in the nation to be certified by MD Anderson Cancer Network®

Community Health Network is the first healthcare organization to achieve system-wide recognition by MD Anderson Cancer Network® as a certified member. The five hospital locations providing qualified cancer services in the network have met the rigorous standards to treat cancer patients with MD Anderson evidence-based guidelines and best practices. Learn more.